Inhibition of FGFR2 enhances chemosensitivity to gemcitabine in cholangiocarcinoma through the AKT/mTOR and EMT signaling pathways
Autor: | Jaidee, Rattanaporn, Kukongviriyapan, Veerapol, Senggunprai, Laddawan, Prawan, Auemduan, Jusakul, Apinya, Laphanuwat, Phatthamon, Kongpetch, Sarinya |
---|---|
Zdroj: | In Life Sciences 1 May 2022 296 |
Databáze: | ScienceDirect |
Externí odkaz: |